| Product Code: ETC8849661 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for premenstrual dysphoric disorder (PMDD) treatment in the Philippines is expanding as awareness about women`s mental and reproductive health increases. PMDD, a severe form of premenstrual syndrome (PMS), requires medical intervention, including hormonal therapies, antidepressants, and lifestyle management solutions. The rising prevalence of stress-related disorders, along with growing healthcare access and awareness campaigns, is fueling the demand for effective treatment options. Pharmaceutical companies and healthcare providers are investing in research and awareness programs to address this condition.
The growing awareness of womens health issues and the increasing recognition of premenstrual dysphoric disorder (PMDD) as a serious medical condition are driving market demand in the Philippines. Rising healthcare access and improved diagnosis of PMDD have led to an increase in treatment-seeking behavior. Additionally, pharmaceutical advancements in hormonal therapies and antidepressants, along with lifestyle-based interventions, are supporting the market growth.
The treatment market for premenstrual dysphoric disorder (PMDD) is constrained by a lack of awareness, misdiagnosis, and limited access to specialized healthcare providers. Many women do not seek medical help due to cultural stigma surrounding mental health conditions.
The increasing awareness of womens health issues in the Philippines is driving the demand for treatments for premenstrual dysphoric disorder (PMDD). Investment opportunities exist in developing specialized medications, hormone therapy options, and mental health support programs. Companies that focus on holistic treatment approaches, including lifestyle-based interventions and digital health support, can cater to a growing segment of the population seeking effective PMDD management.
The government recognizes premenstrual dysphoric disorder (PMDD) as a significant women`s health issue. Policies promote public awareness and education on PMDD, while healthcare providers are encouraged to offer affordable treatment options. The FDA regulates medications prescribed for PMDD to ensure safety and efficacy.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Premenstrual Dysphoric Disorder Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Premenstrual Dysphoric Disorder Market - Industry Life Cycle |
3.4 Philippines Premenstrual Dysphoric Disorder Market - Porter's Five Forces |
3.5 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.8 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Premenstrual Dysphoric Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about premenstrual dysphoric disorder (PMDD) in the Philippines |
4.2.2 Growing acceptance and recognition of PMDD as a legitimate medical condition |
4.2.3 Rising disposable income leading to increased healthcare spending on PMDD treatment |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare providers for diagnosing and treating PMDD |
4.3.2 Societal stigma and misconceptions surrounding mental health issues, including PMDD, leading to underreporting and undertreatment |
5 Philippines Premenstrual Dysphoric Disorder Market Trends |
6 Philippines Premenstrual Dysphoric Disorder Market, By Types |
6.1 Philippines Premenstrual Dysphoric Disorder Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.5 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.6 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Exercise, 2021- 2031F |
6.1.8 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Diet, 2021- 2031F |
6.2 Philippines Premenstrual Dysphoric Disorder Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Premenstrual Dysphoric Disorder Market, By Symptoms |
6.3.1 Overview and Analysis |
6.3.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intense Anger, 2021- 2031F |
6.3.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Mood Swings, 2021- 2031F |
6.3.5 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Irritability, 2021- 2031F |
6.3.6 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Premenstrual Dysphoric Disorder Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Premenstrual Dysphoric Disorder Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Philippines Premenstrual Dysphoric Disorder Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Philippines Premenstrual Dysphoric Disorder Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Philippines Premenstrual Dysphoric Disorder Market Revenues & Volume, By , 2021- 2031F |
7 Philippines Premenstrual Dysphoric Disorder Market Import-Export Trade Statistics |
7.1 Philippines Premenstrual Dysphoric Disorder Market Export to Major Countries |
7.2 Philippines Premenstrual Dysphoric Disorder Market Imports from Major Countries |
8 Philippines Premenstrual Dysphoric Disorder Market Key Performance Indicators |
8.1 Number of public awareness campaigns and educational programs conducted on PMDD |
8.2 Percentage increase in the number of healthcare professionals trained in diagnosing and treating PMDD |
8.3 Patient satisfaction scores related to PMDD treatment services provided |
9 Philippines Premenstrual Dysphoric Disorder Market - Opportunity Assessment |
9.1 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.4 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Philippines Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Premenstrual Dysphoric Disorder Market - Competitive Landscape |
10.1 Philippines Premenstrual Dysphoric Disorder Market Revenue Share, By Companies, 2024 |
10.2 Philippines Premenstrual Dysphoric Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here